IGF1 and Alzheimer disease: For example, in PD patients with cognitive decline or an additional diagnosis of dementia, IGF-1 levels might show a distinct alteration as suggested by findings showing that IGF-1 levels change differently in Alzheimer's disease (AD) and PD [22,48].